SC
AMGN icon

Schubert & Co’s Amgen AMGN Stock Holding History

Schubert & Co’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-90
Closed -$21.8K – 106
2023
Q1 		$21.8K Sell
90
-40
-31% -$9.82K 0.02% 122
2022
Q4 		$34.1K Buy
130
+19
+17% +$5.09K 0.03% 78
2022
Q3 		$25K Buy
111
+15
+16% +$3.64K 0.02% 91
2022
Q2 		$23K Buy
96
+53
+123% +$13K 0.02% 101
2022
Q1 		$10K Buy
43
+9
+26% +$2.07K 0.01% 111
2021
Q4 		$8K Buy
+34
New +$7.18K 0.01% 96

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Schubert & Co's AMGN Position: Q2 2023 in Review

Schubert & Co sold out of Amgen (AMGN) in Q2 2023, closing a stake of 90 shares — an estimated $21.8K sold.

Schubert & Co first reported a position in AMGN in Q4 2021 and held it in 6 quarters. The position peaked at $34.1K in Q4 2022. 2,390 funds tracked by Wall St. Rank hold AMGN as of Q2 2023.

  • Schubert & Co reported no remaining Amgen position as of Q2 2023 after selling out during the quarter.
  • Schubert & Co sold 90 Amgen shares in Q2 2023, an estimated $21.8K.
  • Schubert & Co first reported a position in Amgen in Q4 2021 and held it in 6 quarters.
  • Schubert & Co's Amgen position peaked at $34.1K in Q4 2022.
  • 2,390 funds tracked by Wall St. Rank held Amgen as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.